Roche’s Breast Cancer Drug Perjeta Works in Combination with Herceptin

September 28, 2014 5:32 PM

3 0

Roche’s Breast Cancer Drug Perjeta Works in Combination with Herceptin

Roche’s drug Perjeta has registered encouraging results for women with HER2 positive breast cancer as a combination therapy with Herceptin. The study carried out on 800 women with breast cancer has found an average extension by 16.7 months for metastatic breast cancer.

The study results were presented on Sunday at the European Society for Medical Oncology (ESMO) annual congress in Madrid. Lead researcher Sandra Swain from the Washington Hospital Center termed the results as phenomenal.

Read more

To category page

Loading...